Abnormal Tau Protein Influences Intercellular Mitochondrial Transfer Between Astrocytic and Neuronal Cells
RIOU, A.; Broeglin, A.; Papassotiropoulos, A.; Eckert, A.; Grimm, A.
Show abstract
Tauopathies are a group of neurodegenerative diseases characterized by the pathological accumulation of abnormal tau protein. A consequence of tau pathologies is mitochondrial dysfunctions, which affect essential processes such as mitochondrial transport, bioenergetics, and dynamics. Given the high energy demands of neurons, tau-induced mitochondrial impairment significantly contributes to neuronal vulnerability and degeneration. Recent studies have revealed that cells can transfer mitochondria between them to help energy-deficient cells. This process, known as intercellular mitochondrial transfer, occurs through two different pathways: an indirect transfer via extracellular vesicles and a direct transfer via tunneling nanotubes and gap junctions. Given the known impact of abnormal tau protein on mitochondrial transport and actin filament dynamics, we hypothesized that intercellular mitochondrial transfer could be altered in the context of tauopathies. Therefore, this study aimed to investigate mitochondrial transfer between astrocytic and neuronal cells and assess how abnormal tau protein may influence this process. Our results showed that abnormal tau protein enhances mitochondrial transfer from astrocytic to neuronal cells. Notably, this transfer occurs mainly via contact-dependent mechanisms. In both pathological and healthy conditions, the transferred astrocytic mitochondria either fused with the mitochondrial network of recipient cells or were degraded in the lysosomes or remained isolated in the cytosol. Our data highlight a novel pathway by which abnormal tau protein impacts mitochondrial function, namely the transfer of astrocytic mitochondria to neuronal cells.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Determinants of Astrocytic Pathology in Stem Cell Models of Primary Tauopathies 94%
- Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models 94%
- Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein 93%
Similar papers in this journal
- The DNA methyltransferase 1 (DNMT1) acts on neurodegeneration by modulating proteostasis-relevant intracellular processes 94%
- Live cell imaging of single neurotrophin receptor molecules on human neuron in Alzheimer's disease 94%
- Reduction of HDAC2 expression in human induced pluripotent stem cell derived neurons improves neuronal maturation, mitochondrial dynamics and cellular neurodegenerative disease phenotypes. 93%
Similar papers in this journal
- Induction Of Chronic Stress Reveals An Interplay Of Stress Granules And TDP-43 Pathological Aggregates In Human ALS Fibroblasts And iPSC-Neurons 95%
- Atlastin-1 regulates endosomal tubulation and lysosomal proteolysis in human cortical neurons 94%
- Bioenergetic and Protein Processing Imbalances Synergize in iPSC-Dopamine neurons from Individuals with Idiopathic Parkinsons Disease 94%
Similar papers in this journal
- Targeting tau mitigates mitochondrial fragmentation and oxidative stress in amyotrophic lateral sclerosis 94%
- Cellular and Extracellular microRNA Dysregulation in LRRK2-Linked Parkinson's Disease 94%
- NRF2 deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer's disease 93%
Similar papers in this journal
- Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimers disease reveal intraneuronal Abeta42 accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ flux dysregulation: Therapeutic implications 95%
- Queuine, a bacterial derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration 94%
- Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.